2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …

BR Haugen, EK Alexander, KC Bible, GM Doherty… - Thyroid, 2016 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Molecular genetics and diagnosis of thyroid cancer

YE Nikiforov, MN Nikiforova - Nature Reviews Endocrinology, 2011 - nature.com
Thyroid cancer is a common type of endocrine malignancy, and its incidence has been
steadily increasing in many regions of the world. Initiation and progression of thyroid cancer …

BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications

M Xing - Endocrine reviews, 2007 - academic.oup.com
In recent years, the T1799A B-type Raf kinase (BRAF) mutation in thyroid cancer has
received enthusiastic investigation, and significant progress has been made toward …

Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes

I Sugitani, K Toda, K Yamada, N Yamamoto… - World journal of …, 2010 - Springer
Background Papillary microcarcinoma (PMC) of the thyroid generally follows a benign
clinical course. However, treatment strategies remain controversial. According to our …

Molecular diagnostics of thyroid tumors

YE Nikiforov - Archives of pathology & laboratory medicine, 2011 - meridian.allenpress.com
Context.—Thyroid cancer is the most common type of endocrine malignancy and its
incidence is steadily increasing. Papillary carcinoma and follicular carcinoma are the most …

Molecular diagnostics and predictors in thyroid cancer

MN Nikiforova, YE Nikiforov - Thyroid, 2009 - liebertpub.com
Background: The accuracy of cancer detection in thyroid nodules by fine-needle aspiration
(FNA) cytology and prognostication of thyroid cancer needs further improvement and can …

Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma

X Wei, X Wang, J Xiong, C Li, Y Liao… - BioMed Research …, 2022 - Wiley Online Library
Background. Over the past ten years, the incidence rate of papillary thyroid carcinoma (PTC)
worldwide has been increasing rapidly year by year, with the incidence rate increasing 6 …

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of …

Y Ito, H Yoshida, R Maruo, S Morita, T Takano… - Endocrine …, 2009 - jstage.jst.go.jp
Recent studies have demonstrated that BRAFV600E mutation is a common event in
papillary thyroid carcinoma and a majority of these lesions have shown a direct relationship …

[PDF][PDF] Bone metastases from differentiated thyroid carcinoma

MM Muresan, P Olivier, J Leclère, F Sirveaux… - Endocrine-related …, 2008 - Citeseer
The presence of distant metastases from differentiated thyroid carcinoma decreases the 10-
year survival of patients by 50%. Bone metastases represent a frequent complication …

Prognostic utility of BRAF mutation in papillary thyroid cancer

M Xing - Molecular and cellular endocrinology, 2010 - Elsevier
Papillary thyroid cancer (PTC) is a common endocrine malignancy that frequently harbors
the oncogenic T1799A BRAF mutation. As a novel prognostic molecular marker, this …